BofA cut its price target on UnitedHealth to $300 from $350, citing rising medical costs and uncertainty in Medicare Advantage. UNH reaffirmed 2025 guidance, but EPS fell short of estimates. Shares dropped 7.5%, now down 48.3% YTD. Retail sentiment on Stocktwits turned 'extremely bullish' despite near-term caution from analysts.